17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
As the number of confirmed novel coronavirus cases (COVID-19) continues to grow, we recommend health...
Read More >
Pilot Repeatedly Posted Sexually Explicit Photos of a Flight Attendant To Websites for Years, Federa...
Read More >
Since being enacted in the early 1990s, the Family and Medical Leave Act (FMLA) has provided meaning...
Read More >
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
There are increasing reports that some subcontractors have decided to suspend operations during the ...
Read More >
Title VII, which prohibits employment discrimination on the basis of race, color, religion, sex, and...
Read More >